Search research articles
Contact Us
Filters
Showing results (111-120 of 272) with videos related to
Page
of 28
Sort By:
Immunotherapy
|
May 16, 2019
Clinical significance of signs of autoimmune colitis in <sup>18</sup>F-fluorodeoxyglucose positron emission tomography-computed tomography of 100 stage-IV melanoma patients
Nina Lang, Julika Dick, Alla Slynko, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 26, 2018
The role of interim <sup>18</sup>F-FDG PET/CT in prediction of response to ipilimumab treatment in metastatic melanoma
Christos Sachpekidis, Hoda Anwar, Julia Winkler, et al.
Applied Clinical Informatics
|
October 30, 2025
Development and Evaluation of a Web-Based Outcome Database for Advanced Melanoma with Rare BRAF Mutations
Susanne Dugas-Breit, Christian Menzer, Christian U Blank, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
June 11, 2020
Katharina C Kähler, Jessica C Hassel, Lucie Heinzerling, et al.
The Journal of Investigative Dermatology
|
September 22, 2016
The BRAF Inhibitor Vemurafenib Enhances UV-Induced Skin Carcinogenesis in Beta HPV38 E6 and E7 Transgenic Mice
Daniele Viarisio, Karin Müller-Decker, Jessica C Hassel, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
June 4, 2020
Side effect management during immune checkpoint blockade using CTLA-4 and PD-1 antibodies for metastatic melanoma - an update
Katharina C Kähler, Jessica C Hassel, Lucie Heinzerling, et al.
Cancer Immunology, Immunotherapy : CII
|
June 7, 2018
Longitudinal studies of the <sup>18</sup>F-FDG kinetics after ipilimumab treatment in metastatic melanoma patients based on dynamic FDG PET/CT
Christos Sachpekidis, Hoda Anwar, Julia K Winkler, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 6, 2025
Artificial intelligence-assisted assessment of metabolic response to tebentafusp in metastatic uveal melanoma: a long axial field-of-view [<sup>18</sup>F]FDG PET/CT study
Christos Sachpekidis, Devayani Machiraju, Dimitrios Stefanos Strauss, et al.
Cancer Medicine
|
December 22, 2017
Progression patterns under BRAF inhibitor treatment and treatment beyond progression in patients with metastatic melanoma
Jessica C Hassel, Kristina Buder-Bakhaya, Carolin Bender, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
February 7, 2020
Mareen Zielonka, Daniel Debatin, Arno Rütten, et al.
Page
of 28
Search research articles
Search
Showing results (111-120 of 272) with videos related to
Sort By:
Page
of 28
Immunotherapy
|
May 16, 2019
Clinical significance of signs of autoimmune colitis in <sup>18</sup>F-fluorodeoxyglucose positron emission tomography-computed tomography of 100 stage-IV melanoma patients
Nina Lang, Julika Dick, Alla Slynko, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 26, 2018
The role of interim <sup>18</sup>F-FDG PET/CT in prediction of response to ipilimumab treatment in metastatic melanoma
Christos Sachpekidis, Hoda Anwar, Julia Winkler, et al.
Applied Clinical Informatics
|
October 30, 2025
Development and Evaluation of a Web-Based Outcome Database for Advanced Melanoma with Rare BRAF Mutations
Susanne Dugas-Breit, Christian Menzer, Christian U Blank, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
June 11, 2020
Katharina C Kähler, Jessica C Hassel, Lucie Heinzerling, et al.
The Journal of Investigative Dermatology
|
September 22, 2016
The BRAF Inhibitor Vemurafenib Enhances UV-Induced Skin Carcinogenesis in Beta HPV38 E6 and E7 Transgenic Mice
Daniele Viarisio, Karin Müller-Decker, Jessica C Hassel, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
June 4, 2020
Side effect management during immune checkpoint blockade using CTLA-4 and PD-1 antibodies for metastatic melanoma - an update
Katharina C Kähler, Jessica C Hassel, Lucie Heinzerling, et al.
Cancer Immunology, Immunotherapy : CII
|
June 7, 2018
Longitudinal studies of the <sup>18</sup>F-FDG kinetics after ipilimumab treatment in metastatic melanoma patients based on dynamic FDG PET/CT
Christos Sachpekidis, Hoda Anwar, Julia K Winkler, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 6, 2025
Artificial intelligence-assisted assessment of metabolic response to tebentafusp in metastatic uveal melanoma: a long axial field-of-view [<sup>18</sup>F]FDG PET/CT study
Christos Sachpekidis, Devayani Machiraju, Dimitrios Stefanos Strauss, et al.
Cancer Medicine
|
December 22, 2017
Progression patterns under BRAF inhibitor treatment and treatment beyond progression in patients with metastatic melanoma
Jessica C Hassel, Kristina Buder-Bakhaya, Carolin Bender, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
February 7, 2020
Mareen Zielonka, Daniel Debatin, Arno Rütten, et al.
Page
of 28